Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,070Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Azilect

PharmaCompass

01

Brand Name : Azilect

Rasagiline Mesylate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Azilect

arrow
Antibody Engineering
Not Confirmed

Rasagiline Mesylate

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : 15.40%

2013 Revenue in Millions :

Growth (%) :

blank

02

Brand Name : Azilect

Rasagiline Mesylate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Azilect

arrow
Antibody Engineering
Not Confirmed

Rasagiline Mesylate

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 225

2014 Revenue in Millions : 219

Growth (%) : -3%

blank

03

Brand Name : Azilect

Rasagiline Mesylate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Azilect

arrow
Antibody Engineering
Not Confirmed

Rasagiline Mesylate

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : 8%

2013 Revenue in Millions :

Growth (%) :

blank

04

Brand Name : Azilect

Rasagiline Mesylate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Azilect

arrow
Antibody Engineering
Not Confirmed

Rasagiline Mesylate

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 428

2014 Revenue in Millions : 384

Growth (%) : -10%

blank

05

Brand Name : Azilect

Rasagiline Mesylate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Azilect

arrow
Antibody Engineering
Not Confirmed

Rasagiline Mesylate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 410

2015 Revenue in Millions : 384

Growth (%) : 7

blank

06

Brand Name : Azilect

Rasagiline Mesylate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Azilect

arrow
Antibody Engineering
Not Confirmed

Rasagiline Mesylate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 170

2016 Revenue in Millions : 410

Growth (%) : -59

blank